Comments
-
Pharma jobs pay the price for PBS squeeze
- Fri May 29
Australia may not be the attractive market for medicines it once was, but there is still an opportunity to change its downward trajectory.
Read more -
Butler for PM? His cherry-picking could cost him
- Wed May 20
Mark Butler’s PM prospects are reportedly on the rise, but his selective memory when it comes to cherries may yet return to haunt him.
Read more -
Butler drops smoking bomb on pharma
- Sat May 16
MA members almost choked on their breakfasts this week as Health Minister Mark Butler served up some tough medicine at consecutive Budget events.
Read more -
Will PBS be the scapegoat for Budget blowouts?
- Mon May 11
Is the PBS is the envy of the world or a runaway cost centre? As the gap between political narrative and fiscal reality widens, pharma has to decide to play along, or take a hit.
Read more -
Will new look MA Board make a difference?
- Mon May 4
MA members have weighted the Board in favour of local GMs and smaller companies reps. Does it now have what it takes to make a difference?
Read more -
‘Tell ’em they’re dreaming’
- Wed Apr 29
PBAC is pushing on, recommending new therapies with big price cuts and strict patient caps, ignoring the reality of the New World Order.
Read more -
Ballet lessons or cancer medicines?
- Fri Apr 24
Labor presided over NDIS cost blow-outs that eclipsed annual PBS spending. How did it get priorities so wrong, and why are patients ignored?
Read more -
ADHD is complex. Our public conversation should be too.
- Mon Apr 20
Simplified narratives are compelling but health stakeholders have a shared responsibility to promote a balanced conversation, writes Takeda GM Dave Pearce.
Read more -
Defence gets billions, patients get bargains
- Wed Apr 15
Australia doesn’t expect to buy defence equipment at a bargain price, so why is a company ‘greedy’ in demanding a fair price for its medicine?
Read more -
Why healthcare comms needs more courage
- Wed Apr 8
Healthcare communications in Australia doesn’t need more activity; it needs more courage, writes guest author Will Collie.
Read more